𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Design aspects for clinical trials with repeated measures in the presence of informative censoring

✍ Scribed by Margaret C. Wu

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
935 KB
Volume
42
Category
Article
ISSN
0378-3758

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

On the appropriateness of marginal model
On the appropriateness of marginal models for repeated measurements in clinical trials
✍ J. K. Lindsey; P. Lambert πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 2 views

Although models developed directly to describe marginal distributions have become widespread in the analysis of repeated measurements, some of their disadvantages are not well enough known. These include producing profile curves that correspond to no possible individual, possibly showing that a trea

Measuring the rate of progression in Fri
Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design
✍ Lisa S. Friedman; Jennifer M. Farmer; Susan Perlman; George Wilmot; Christopher πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract Friedreich ataxia is an autosomal recessive neurodegenerative disorder characterized by ataxia of all four limbs, dysarthria, and arreflexia. A variety of measures are currently used to quantify disease progression, including the Friedreich Ataxia Rating Scale, examiner‐rated functional